Use of risperidone in children with epilepsy

Epilepsy and Behavior

Volumn 10, Issue 3, 2007, Pages 412-416

  Holzhausen, Stefan Padial Ferri ^a   Guerreiro, Marilisa Mantovani ^a   Baccin, Carlos Eduardo ^a   Montenegro, Maria Augusta ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Aggression; Childhood; Epilepsy; Risperidone

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; LAMOTRIGINE; NITRAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; RISPERIDONE; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; AGGRESSION; AGITATION; ARTICLE; AUTOMUTILATION; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CHILD; CHILD BEHAVIOR; COMBINATION CHEMOTHERAPY; COMORBIDITY; DISEASE EXACERBATION; DRUG DOSE TITRATION; DRUG RESPONSE; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT COMPLIANCE; PROGNOSIS; SEIZURE; SIDE EFFECT; SOMNOLENCE;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISPERIDONE; SEIZURES;

EID: 34147129099     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2007.02.005     Document Type: Article

References (22)

1. Noutros N.N., Juo-Tzu J., Shehata M., et al. Epileptic psychiatric patients, a special population. J Ment Health 1 (1995) 79-83
2. Bihm E.M., Poindexter A.R., and Warren E.R. Aggression and psychopathology in persons with severe or profound mental retardation. Res Dev Disabil 19 (1998) 423-438
3. Ettinger A.B., Weisbrot D.M., Nolan E.E., et al. Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 39 (1998) 595-599
4. Ettinger A.B., Reed M.L., Goldberg J.F., and Hirschfeld R.M. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology 65 (2005) 535-540
5. Pisani F., Oteri G., Costa C., Di Raimondo G., and Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saf 25 (2002) 91-110
6. Hedges D., Jeppson K., and Whitehead P. Antipsychotic medication and seizures: a review. Drugs Today (Barc) 39 (2003) 551-557
7. Koch-Stoecker S. Antipsychotic drugs and epilepsy: indications and treatment guidelines. Epilepsia 43 Suppl. 2 (2002) 19-24
8. Wyderski R.J., Starrett W.G., and Abou-Saif A. Fatal status epilepticus associated with olanzapine therapy. Ann Pharmacother 33 (1999) 787-789
9. Dubois D. Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer?. Curr Opin Pediatr 17 (2005) 227-233
10. Heykants J., Huang M.L., Mannens G., et al. The pharmacokinetics of risperidone in humans: a summary. J Clin Psychiatry 55 (1994) 13-17
11. Alldredge B.K. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology 53 Suppl. 2 (1999) S68-S75
12. Gonzalez-Heydrich J., Pandina G.J., Fleisher C.A., et al. No seizure exacerbation from risperidone in youth with comorbid epilepsy and psychiatric disorders: a case series. J Child Adolesc Psychopharmacol 14 (2004) 295-310
13. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
14. Aman M.G. Gharabawi G.M. for the Special Topic Advisory Panel on Transitioning to Risperidone Therapy in Patients with Mental Retardation and Developmental Disabilities. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone. J Clin Psychiatry 65 (2004) 1197-1210
15. Simon E.W., Blubaugh K.M., and Pippidis M. Substituting traditional antipsychotics with risperidone for individuals with mental retardation. Ment Retard 34 (1996) 359-366
16. Gazdag G., Barna I., Ivanvi Z., and Tolna J. The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy. Ideggyogy Sz 57 (2004) 385-390
17. Centorrino F., Price B.H., Tuttle M., et al. EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry 159 (2002) 109-115
18. Amann B.L., Pogarell O., Mergl R., et al. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Hum Psychopharmacol 18 (2003) 641-646
19. Devinsky O., Honigfeld G., and Patin J. Clozapine-related seizures. Neurology 41 (1991) 369-371
20. Silvestri R.C., Bromfield E.B., and Khoshbin S. Clozapine-induced seizures and EEG abnormalities in ambulatory psychiatric patients. Ann Pharmacother 32 (1998) 1147-1151
21. Risperdal: full U.S. prescribing information. Available at: http://www.risperdal.com/html/pris/prescribing.jsp.
22. Singh A.N., Matson J.L., Cooper C.L., Dixon D., and Sturmey P. The use of risperidone among individuals with mental retardation: clinically supported or not?. Res Dev Disabil 26 (2005) 203-218